Showing results (1421-1430 of 1,500) with videos related to
Sort By:
Pageof 150
Chemsuschem|August 16, 2019
Manipulating the Optical Properties of Carbon Dots by Fine-Tuning their Structural FeaturesHui Luo, Nikolaos Papaioannou, Enrico Salvadori, et al.Clinical Rheumatology|May 16, 2025
Prevalence of and risk factors for important comorbidities of systemic lupus erythematosus using data from a multicenter Chinese cohort registry: A cross-sectional studyMinhui Wang, Jiaxin Zhou, Feng Zhan, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|September 12, 2013
Clearance of free silica in rat lungs by spraying with chinese herbal kombuchaNai-Fang Fu, Chang-Hui Luo, Jun-Cai Wu, et al.Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 2, 2008
[Effectiveness of an immunization campaign with group A and C meningococcal polysaccharide vaccine in controlling an outbreak of group C meningococcal disease]Jian Gong, Cui-Yun Li, Bai-Qing Dong, et al.Neuro-Oncology|June 22, 2014
MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1Rui Zhang, Hui Luo, Shuai Wang, et al.Cancer Research|August 26, 2024
Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell CarcinomaLiting Zhou, Jie Tian, Keke Wang, et al.Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion|July 6, 2022
[Clinical observation on filiform-fire needling of "<i>Biaoben</i> acupoint combination" for 33 cases of sequelae of coronavirus disease 2019 during recovery period]Zhi-Hui Luo, Kun-Xiu Wang, Yan-Lin Zhang, et al.Cell Metabolism|April 5, 2018
AIDA Selectively Mediates Downregulation of Fat Synthesis Enzymes by ERAD to Retard Intestinal Fat Absorption and Prevent ObesityHui Luo, Ming Jiang, Guili Lian, et al.Clinical and Experimental Medicine|March 9, 2022
The effect of discontinuation of maintenance therapy in Chinese patients with MPO-ANCA associated vasculitis who were in long-term stable remissionPeng Zhu, Ting Meng, Chanjuan Shen, et al.The Journal of Allergy and Clinical Immunology|May 30, 2020
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trialYang Cao, Jia Wei, Liang Zou, et al.Pageof 150